Despite their relatively poor in vivo expansion, adoptively transferred TRP-1 CD4+ T cells eradicated established B16 melanomas as efficiently as Pmel-1 CD8+ T cells (Fig. 1h and Extended Data Fig. 2c,d). This evidence concerns the gene CD4 and melanoma.